171 related articles for article (PubMed ID: 37798830)
1. Impact of the COVID-19 Pandemic on the Management of Juvenile Idiopathic Arthritis: Analysis of United States Commercial Insurance Data.
Horton DB; Yang Y; Neikirk A; Huang C; Crystal S; Davidow A; Haynes K; Gerhard T; Rose CD; Strom BL; Parlett L
J Clin Rheumatol; 2023 Dec; 29(8):388-395. PubMed ID: 37798830
[TBL] [Abstract][Full Text] [Related]
2. Treatment of patients with juvenile idiopathic arthritis (JIA) in a population-based cohort.
Zamora-Legoff JA; Krause ML; Crowson CS; Muskardin TW; Mason T; Matteson EL
Clin Rheumatol; 2016 Jun; 35(6):1493-9. PubMed ID: 26825065
[TBL] [Abstract][Full Text] [Related]
3. Summary of AHRQ's Comparative Effectiveness Review of Disease-Modifying Antirheumatic Drugs for Children with Juvenile Idiopathic Arthritis.
McMahan R; Balfe LM; Greene L
J Manag Care Pharm; 2012; 18(1 Suppl B):1-16. PubMed ID: 22376227
[TBL] [Abstract][Full Text] [Related]
4. Incidence Rates of Psoriasis in Children With Inflammatory Bowel Disease and Juvenile Arthritis Treated With Tumor Necrosis Factor Inhibitors and Disease-Modifying Antirheumatic Drugs.
Baggett K; Brandon TG; Xiao R; Valenzuela Z; Buckley LH; Weiss PF
J Rheumatol; 2022 Aug; 49(8):935-941. PubMed ID: 35428721
[TBL] [Abstract][Full Text] [Related]
5. Decreasing trend in the incidence of serious pneumonias in Finnish children with juvenile idiopathic arthritis.
Salonen PH; Salonen JH; Säilä H; Helminen M; Linna M; Kauppi MJ
Clin Rheumatol; 2020 Mar; 39(3):853-860. PubMed ID: 31732822
[TBL] [Abstract][Full Text] [Related]
6. Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register.
Otten MH; Anink J; Prince FH; Twilt M; Vastert SJ; ten Cate R; Hoppenreijs EP; Armbrust W; Gorter SL; van Pelt PA; Kamphuis SS; Dolman KM; Swart JF; van den Berg JM; Koopman-Keemink Y; van Rossum MA; Wulffraat NM; van Suijlekom-Smit LW
Ann Rheum Dis; 2015 Jul; 74(7):1379-86. PubMed ID: 24641940
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid treatment in juvenile idiopathic arthritis.
Batu ED
Rheumatol Int; 2019 Jan; 39(1):13-27. PubMed ID: 30276425
[TBL] [Abstract][Full Text] [Related]
8. Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis.
Beukelman T; Xie F; Baddley JW; Chen L; Delzell E; Grijalva CG; Mannion ML; Patkar NM; Saag KG; Winthrop KL; Curtis JR;
Arthritis Rheum; 2013 May; 65(5):1384-9. PubMed ID: 23460423
[TBL] [Abstract][Full Text] [Related]
9. Transition to adult rheumatology care is necessary to maintain DMARD therapy in young people with juvenile idiopathic arthritis.
Luque Ramos A; Hoffmann F; Albrecht K; Klotsche J; Zink A; Minden K
Semin Arthritis Rheum; 2017 Oct; 47(2):269-275. PubMed ID: 28583690
[TBL] [Abstract][Full Text] [Related]
10. Real-world data reveals the complexity of disease modifying anti-rheumatic drug treatment patterns in juvenile idiopathic arthritis: an observational study.
Grazziotin LR; Currie G; Twilt M; Ijzerman MJ; Kip MMA; Koffijberg H; Benseler SM; Swart JF; Vastert SJ; Wulffraat NM; Yeung RSM; Marshall DA
Pediatr Rheumatol Online J; 2022 Apr; 20(1):25. PubMed ID: 35410419
[TBL] [Abstract][Full Text] [Related]
11. Trends towards more active introduction of drug therapy, emphasizing methotrexate and biologic agents, for juvenile idiopathic arthritis.
Pohjankoski H; Kautiainen H; Lauri JV; Puolakka K; Rantalaiho V
Clin Rheumatol; 2020 Jan; 39(1):263-268. PubMed ID: 31346886
[TBL] [Abstract][Full Text] [Related]
12. Mental comorbidities in adolescents and young adults with juvenile idiopathic arthritis: an analysis of German nationwide health insurance data.
Milatz F; Albrecht K; Minden K; Marschall U; Klotsche J; Callhoff J
Pediatr Rheumatol Online J; 2024 Jan; 22(1):10. PubMed ID: 38183044
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with treatment response to etanercept in juvenile idiopathic arthritis.
Otten MH; Prince FH; Armbrust W; ten Cate R; Hoppenreijs EP; Twilt M; Koopman-Keemink Y; Gorter SL; Dolman KM; Swart JF; van den Berg JM; Wulffraat NM; van Rossum MA; van Suijlekom-Smit LW
JAMA; 2011 Dec; 306(21):2340-7. PubMed ID: 22056397
[TBL] [Abstract][Full Text] [Related]
14. Recent therapeutic advances in juvenile idiopathic arthritis.
Giancane G; Alongi A; Rosina S; Tibaldi J; Consolaro A; Ravelli A
Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):476-487. PubMed ID: 29773268
[TBL] [Abstract][Full Text] [Related]
15. Response to treatment with intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligo articular juvenile idiopathic arthritis.
Harhay R; Jeelani W; Agbor BTA; Hennon T; Wrotniak BH; Abdul-Aziz R
Pediatr Rheumatol Online J; 2021 Mar; 19(1):36. PubMed ID: 33743721
[TBL] [Abstract][Full Text] [Related]
16. Rates of malignancy associated with juvenile idiopathic arthritis and its treatment.
Beukelman T; Haynes K; Curtis JR; Xie F; Chen L; Bemrich-Stolz CJ; Delzell E; Saag KG; Solomon DH; Lewis JD;
Arthritis Rheum; 2012 Apr; 64(4):1263-71. PubMed ID: 22328538
[TBL] [Abstract][Full Text] [Related]
17. The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation.
Shepherd J; Cooper K; Harris P; Picot J; Rose M
Health Technol Assess; 2016 Apr; 20(34):1-222. PubMed ID: 27135404
[TBL] [Abstract][Full Text] [Related]
18. Use of Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Juvenile Idiopathic Arthritis or Rheumatoid Arthritis.
Lee WJ; Briars L; Lee TA; Calip GS; Suda KJ; Schumock GT
Pharmacotherapy; 2016 Dec; 36(12):1201-1209. PubMed ID: 27779782
[TBL] [Abstract][Full Text] [Related]
19. Negative effect of lockdown on juvenile idiopathic arthritis patients.
Conti G; Galletta F; Carucci NS; La Mazza A; Mollica SA; Alibrandi A; Visalli C
Clin Rheumatol; 2021 Sep; 40(9):3723-3727. PubMed ID: 33733314
[TBL] [Abstract][Full Text] [Related]
20. Medication burden in young adults with juvenile idiopathic arthritis: data from a multicentre observational study.
Montag LJ; Horneff G; Hoff P; Klein A; Kallinich T; Foeldvari I; Seipelt E; Tatsis S; Peer Aries MD; Niewerth M; Klotsche J; Minden K
RMD Open; 2022 Oct; 8(2):. PubMed ID: 36283758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
